Summary
The following article summarises a round-up of present understanding and developments reflected in current and planned prevention trials, as discussed at a EU / US / Clinical Trials in Alzheimer’s Disease (CTAD) Task Force meeting, as of December 2016-7.
Reference
Aisen, P. Touchon, J. [and] Amariglio, R. [et al] (2017). EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer’s Prevention Trials. Journal of Prevention of Alzheimer’s Disease. December 11th 2017; 4(2): 116-124.